Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cipla is a leading global pharmaceutical company headquartered in Mumbai, India, with a strong focus on making healthcare accessible and affordable. The company is widely recognized for its extensive portfolio of generic medicines and its pioneering role in providing low-cost antiretroviral drugs for HIV/AIDS treatment in developing nations. Cipla's business spans across several therapeutic areas, including respiratory, cardiovascular, arthritis, diabetes, and oncology. One of its most prominent brands is Azee, a widely used formulation of the antibiotic azithromycin. With a robust manufacturing presence and a commitment to research and development, Cipla continues to expand its footprint in both emerging and regulated markets worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Azee.